Physician profile
Scott Clulow
NPI 1174518310
$6,051.66
in general payments reported to CMS, 2019-2025
36 companies · $962 in 2025
The $962 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $198 · 2021: $146 · 2022: $1,402 · 2023: $1,348 · 2024: $1,205 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,514.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $908.13 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $686.32 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $677.46 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $649.17 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $483.94 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $416.24 | 2019-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $336.44 | 2019-2025 | |
| Exact Sciences Corporation | $321.27 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $254.78 | 2022-2025 | |
| Boston Scientific Corporation | $186.58 | 2019-2024 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.51 | 2019-2024 | Jardiance, Tradjenta |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $88.70 | 2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $86.26 | 2019-2022 | |
| Astellas Pharma US INC | $73.74 | 2019-2023 | Veozah |
| Biohaven Pharmaceutical Holding Company Ltd. | $64.09 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.59 | 2019-2025 | Xifaxan |
| Dexcom, INC. | $57.55 | 2023-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $56.10 | 2023-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $44.64 | 2019-2021 | |
| Allergan, INC. | $41.69 | 2022 | |
| Idorsia Pharmaceuticals US INC | $36.25 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $32.47 | 2022-2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Vanda Pharmaceuticals INC. | $32.14 | 2023 | Hetlioz |
| Antares Pharma, INC. | $31.30 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Philips North America LLC | $31.27 | 2024 | (Ck7) Extended Holter |
| Daiichi Sankyo INC. | $28.32 | 2024 | Injectafer |
| Teva Pharmaceuticals USA, INC. | $27.87 | 2019-2020 | |
| Inari Medical, INC. | $24.21 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $23.99 | 2022 | |
| Nevro Corp. | $22.87 | 2023 | Senza |
| Radius Health, INC. | $21.72 | 2019 | |
| Amarin Pharma, INC. | $21.23 | 2019 | |
| Integra Lifesciences Corporation | $21.06 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.54 | 2020 | |
| Paratek Pharmaceuticals, INC. | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Clulow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.